BLLYF 80 Mile Plc

$BLLYF $GLND DONT LET THE HEDGE FUNDS GOBBLE UP ALL THE SHARES .. You dont want this taken away from you ..

$BLLYF $GLND What this deal does for GLND: 1. Grants 100% access to Jameson bay - $1.4tn in oil. 2. Gives every common share holder a right for up to 1 warrant 3. Provides around $62M ARR through biodiesel and around $2M ARR from other European energy products. 4. Grants access to Disko, a copper/other metals valued at upwards of $25 Billion This means the exploration and drill will be FUNDED without any dilution. The warrants offset the dilution of the merger, but the float will increase. This will take the combined entity upwards of $1TN market cap, likely closer to $2 trillion.

$BLLYF I guess Im the only one buying this stock ? I must be dumb because I think its a screaming buy.

$BLLYF $GLND If you are into Jameson then BUY 80 mile BLLYF because the hold the licences. Also very discounted to GLND.

$BLLYF $GLND merger to close 10/6 Using the latest prices I found: * BLLYF: about $0.0204/share * 1,000,000 BLLYF shares today: $20,400 at that quoted price. If you’re asking what those 1 million BLLYF shares would be worth after the GLND merger, that’s a different calculation because the proposed exchange ratio is 0.01108 GLND shares for each BLLYF share. That would give you: 1,000,000 × 0.01108 = 11,080 GLND shares At GLND’s latest reported $5.54 close: 11,080 × $5.54 = $61,383 So, approximately: Position Value 1M BLLYF today @ $0.0204 $20,400 1M BLLYF → 11,080 GLND 11,080 GLND shares At GLND $5.54 $61,383 That’s roughly 3× the current BLLYF value, if the proposed exchange ratio remains unchanged and the merger closes.

$BLLYF Readers: if you are an IP investor interested in Genoptic, this may be worth reading and sharing. I rarely give advice on any ticker I hold or have held. Some of my followers know my Asymmetric Validation Model (AVM). Genoptic came onto my radar through a casual meeting at my local sports centre. I was given a personal pitch deck during a coffee meeting with Darryl Copeland, Business Development Lead at Genoptic LED Inc. Disclosure: I am not compensated by Genoptic and I currently hold no shares. I’ll explain why. Genoptic is currently at the late-Seed / pre-Series A stage and describes its current financing as a US$5M Seed round. That's outside my investment range, so I’m not participating. But sharing is caring. Genoptic reports 151 IP assets across 24 patent families. If that doesn't interest you, simply move on. If it does, the DD may be worth your time.